机构:[1]Department of Rheumatology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China (mainland).[2]Department of Chinese Medicine, South China Agricultural University Hospital, Guangzhou, Guangdong, China (mainland).[3]Guangzhou Bai Yun Shan Chen Li Ji Pharmaceutical Factory Co., Ltd., Guangzhou, Guangdong, China (mainland).[4]Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China (mainland).深圳市中医院深圳医学信息中心[5]Department of Rheumatology, Oregon Health and Science University, Portland, OR, USA.[6]University of Rochester, Rochester, NY, USA.
BACKGROUND This study was to investigate the correlation between osteoporosis and serum uric acid in ankylosing spondylitis (AS) patients, and to further identify potential factors that might be associated with osteoporosis in AS patients. MATERIAL AND METHODS We included 182 AS patients, consisted of 143 male patients and 39 female patients, who visited our hospital from January 1, 2014 to December 31, 2018. We used dual-energy x-ray absorptiometry to measure bone mineral density (BMD) of orthotopic lumbar vertebrae in patients with AS. The gender, age, disease duration, BMD, T-score, Z-score, uric acid, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), blood platelet (PLT), and status of treatment with biologics of the patients were collected. Then, the Spearman correlation coefficient and multivariate liner regression analysis were applied to identify the relationship between the factors and BMD, T-score, and Z-score in AS patients. RESULTS Male AS patients between the ages of 16 and 30 years old had a higher risk of osteoporosis (P<0.05). AS patients with uric acid value between 300-360 μmol/L had the highest BMD, T-score, and Z-score. The BMD had a positive correlation with age and disease duration (P<0.01) while had a negative correlation with PLT (P<0.05). BMD in AS patients with elevated ESR was significantly (P<0.05) lower than in AS patients with normal ESR. There were no significant differences in BMD between AS patients with elevated CRP and the patients with normal CRP and PLT. Treatment with TNFi (tumor necrosis factor alpha inhibitor) did not improve BMD in AS patients. CONCLUSIONS The relationship between uric acid and BMD in AS patients was observed as inverted "U"-type. Keeping uric acid within 300-360 μmol/L might be helpful in preventing AS patients from developing osteoporosis.
基金:
2019 Science Fund from Traditional Chinese Medicine Bureau of Guangdong Province (No. 20191110), and Guangzhou Science Technology and Innovation Commission (No. 201904010177)
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类|4 区医学
小类|4 区医学:研究与实验
最新[2025]版:
大类|4 区医学
小类|4 区医学:研究与实验
第一作者:
第一作者机构:[1]Department of Rheumatology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China (mainland).[2]Department of Chinese Medicine, South China Agricultural University Hospital, Guangzhou, Guangdong, China (mainland).
共同第一作者:
通讯作者:
通讯机构:[1]Department of Rheumatology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China (mainland).[4]Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China (mainland).
推荐引用方式(GB/T 7714):
Chen Zhixin,Yang Peidan,Wu Yuyun,et al.Serum Uric Acid Shows Inverted "U" Type Correlation with Osteoporosis in Chinese Ankylosing Spondylitis Patients: A Retrospective Study.[J].Medical science monitor : international medical journal of experimental and clinical research.2019,25:9702-9711.doi:10.12659/MSM.918766.
APA:
Chen Zhixin,Yang Peidan,Wu Yuyun,Liu Xiaobao,Yang Yechun...&Xu Qiang.(2019).Serum Uric Acid Shows Inverted "U" Type Correlation with Osteoporosis in Chinese Ankylosing Spondylitis Patients: A Retrospective Study..Medical science monitor : international medical journal of experimental and clinical research,25,
MLA:
Chen Zhixin,et al."Serum Uric Acid Shows Inverted "U" Type Correlation with Osteoporosis in Chinese Ankylosing Spondylitis Patients: A Retrospective Study.".Medical science monitor : international medical journal of experimental and clinical research 25.(2019):9702-9711